Avidity Partners Management LP - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Avidity Partners Management LP ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q2 2023$15,146,508
-13.6%
1,671,800
-30.7%
0.53%
-9.1%
Q1 2023$17,532,332
-1.1%
2,411,600
-0.9%
0.58%
+51.6%
Q4 2022$17,732,196
-18.7%
2,432,400
-13.7%
0.38%
-13.3%
Q3 2022$21,799,0002,820,0000.44%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,383,029$24,594,6214.83%
Velan Capital Investment Management LP 494,136$3,592,3693.06%
BVF INC/IL 10,563,748$76,798,4482.81%
JOHNSON & JOHNSON 1,000,000$7,270,0002.36%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,925,7071.16%
PFM Health Sciences, LP 3,204,790$23,298,8231.03%
Pier Capital, LLC 862,736$6,272,0910.95%
Boxer Capital, LLC 2,500,000$18,1750.89%
Deep Track Capital, LP 2,345,073$17,048,6810.70%
SILVERARC CAPITAL MANAGEMENT, LLC 198,477$1,442,9280.60%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders